創世紀(300083.SZ):港榮投資擬通過債轉股取得深圳創世紀10.27%股權
格隆匯 7 月 23日丨創世紀(300083.SZ)公佈,公司及子公司深圳市創世紀機械有限公司(“深圳創世紀”)近日與四川港榮投資發展集團有限公司(“港榮投資”)簽署了《四川港榮投資發展有限公司與廣東勁勝智能集團股份有限公司、安徽高新金通安益二期創業投資基金(有限合夥)、新疆榮耀創新股權投資合夥企業(有限合夥)、石河子市隆華匯股權投資合夥企業(有限合夥)關於深圳市創世紀機械有限公司之債轉股協議》,協議約定港榮投資通過債轉股取得深圳創世紀的10.27%股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.